Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep681 | Pituitary: basic and neuroendocrinology | ECE2015

Clinical case of TSH-secreting pituitary adenoma

Lipatenkova Anna , Dzeranova Larisa , Pigarova Ekaterina , Astafieva Liudmila

TSH-secreting pituitary adenoma (thyrotropinoma) is a rare (0.5% of all pituitary adenomas) and usually benign pituitary lesion, arising from the monoclonal expansion of neoplastic thyrotrophes. Thyrotropinoma usually presents with symptoms thyrotoxicosis (milder compared to those originating from the primary thyroid disorders) and mass effects of the pituitary tumour.Aim: To describe the clinical course of thyrotropinoma presented with paroxysmal atrial...

ea0035p119 | Calcium and Vitamin D metabolism | ECE2014

Levels of vitamin D in patients with various endocrine disorders

Pigarova Ekaterina , Dzeranova Larisa , Rozhinskaya Liudmila , Il'in Alexander , Melnichenko Galina

Introduction: The important aspect of vitamin D (vitD) sufficiency is the impact of chronic diseases and medications, which disturb the metabolism of vitD. Bone pathology is common in diseases of the endocrine system, so the determining the status of vitD in various endocrine diseases and comparing it to otherwise healthy controls is of particular interest.Materials and methods: The study included 16 patients with type 2 diabetes mellitus (T2DM), 23 pati...

ea0035p574 | Endocrine tumours and neoplasia | ECE2014

A clinical case of effective treatment of giant prolactinoma in patient with morbid obesity

Vorotnikova Svetlana , Dzeranova Larisa , Pigarova Ekaterina , Markina Natalya

Introduction: Numerous literature sources indicate the potential role of hyperprolactinemia in the development of obesity. Prolactin modulates the functional activity of several enzymes and transporters in adipose tissue and islets of Langerhans, potentially influencing fat and glucose metabolism. On the other hand, elevated prolactin level may induce eating disorders due to dysfunction of dopaminergic regulation of the CNS. We present a clinical case of a man with morbid obes...

ea0035p915 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Clinical case: Silent corticotroph pituitary macroadenoma transforming into Cushing disease.

Lipatenkova Anna , Dzeranova Larisa , Pigarova Ekaterina , Ektova Anastasia

Introduction: The silent corticotropinomas (SC) account for 1.1–6% of surgically removed pituitary adenomas and 17–22% of ACTH-immunoreactive tumours. They do not cause prominent clinical features of hypercortisolism, nor biochemically evident, but show positive immunostaining for ACTH similar to functional corticotropinomas, They usually present as non-functioning adenomas (NFPA) with local mass effects and/or visual impairment.Aim: To describ...

ea0035p919 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Copeptin in basal conditions and during water deprivation test in patients with polydipsic–polyuric disorders

Pigarova Ekaterina , Dzeranova Larisa , Rozhinskaya Liudmila , Melnichenko Galina , Dedov Ivan

Introduction: Copeptin is a proposed new diagnostic marker in differential diagnosis of diabetes insipidus as it is secreted in equimolar concentrations with vasopressin. Thus our aim was to assess diagnostic value of copeptin evaluation in patients with polydipsic-polyuric disorders.Materials and Methods: We’ve evaluated the copeptin (BRAHMS CT-proAVP Kryptor), sodium levels and blood/urine osmolality in 26 healthy volunteers (1M/25F, mean age 24.7...

ea0070aep210 | Bone and Calcium | ECE2020

Is the assessment of clinical risk factors for vitamin D deficiency sufficient?

Pigarova Ekaterina , Vorotnikova Svetlana , Korolenko Andrey , Dzeranova Larisa , Rozhinskaya Liudmila

Introduction: Extremely low levels of vitamin D usually include levels < 4 ng/ml, which is almost the same as undetectable. The risk groups for vitamin D deficiency have been identified, but do they allow such patients to be identified based solely on clinical presentation.Objective: To identify risk factors and their actual clinical determination in patients with 25(OH)D serum levels <4 ng/ml.Materials and methods: The stu...

ea0070aep703 | Pituitary and Neuroendocrinology | ECE2020

Cabergoline resistance in a patient with prolactinoma with debut before puberty

Fedorova Natalia , Dzeranova Larisa , Pigarova Ekaterina , Vorotnikova Svetlana

Prolactinomas are the most common hormone-active pituitary tumors, most common in young women, whose main reason for going to the doctor is menstrual irregularity. At the onset of the disease before puberty in children, there is a delay in sexual development, in girls primary amenorrhea.A 27-year old woman has been observed since 15 years, when hyperprolactinemia was first detected, level of PRL was 10 900 IU/l, and according to MRI pituitary endose...

ea0070aep719 | Pituitary and Neuroendocrinology | ECE2020

Experience in complex therapy of selective and non-selective dopamine agonists in women with resistant prolactinomas for recovering of ovulation function

Vorotnikova Svetlana , Dzeranova Larisa , Pigarova Ekaterina , Fedorova Natalia

Experience in complex therapy of selective and non-selective dopamine agonists in women with resistant prolactinomas for recovering of ovulation function.Introduction: Prolactinomas are the most common pituitary adenomas and dopamine agonists (DA) still remain the first choice of treatment. Nevertheless, it does not always exert an adequate effect and endocrinologists face the challenge of resistant prolactinomas more frequently. This problem is very imp...

ea0032p713 | Neuroendocrinology | ECE2013

Clinical case of silent corticotropinoma

Dzeranova Larisa , Lipatenkova Anna , Pigarova Ekaterina , Voronkova Iya

Silent corticotropinomas (SCAs) are a subtype of non-functioning pituitary adenomas (NFPAs) demonstrating positive immunoreactivity for ACTH, but without clinical or biochemical features of hypercortisolism. SCAs typically present as macroadenomas with symptoms related to a local mass effect. In some cases SCAs can transform into hormonal active formations with gradually developing symptoms of hypercortisolism.The aim: To describe a patient with NFPA who...

ea0032p951 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Syndrome of inappropriate antidiuresis due to low dose hydrochlorothiazide use in a patient after transsphenoidal surgery for pituitary adenoma

Mikhaylova Daria , Vorotnikova Svetlana , Pigarova Ekaterina , Grigor'ev Andrey , Dzeranova Larisa

Introduction: Hyponatriemia is one of severe postoperative water-electrolyte disturbances. This condition is usually caused by syndrome of inappropriate secretion of antidiuretic hormone or cerebral salt-wasting syndrome which require different treatment approaches.Case presentation: A 61-year-old woman was referred to tertiary care center with non-functioning pituitary macroadenoma. The patient had been suffering from headaches for 4 later years and had...